Macroeconomics: The Week Ahead: 6 to 10 February
Written by Marc Ostwald, ADMISI’s Global Strategist & Chief Economist
The new week’s calendar is quite light on economic data with the exception of the UK, but will see peak volume in terms of the Q4 earnings season, with 93 S&P 500 companies. Statistically the US has Trade, Consumer Credit, preliminary Michigan Sentiment and annual CPI revisions; Q4 GDP tops the UK run, accompanied by the usual array of monthly business and trade activity indicators, BRC Retail Sales and RICS House Price survey; German publishes its delayed CPI data along with Factory Orders and Industrial Production, while PPI, CPI and credit aggregates are on tap in China. Japan looks to Wages, Household Spending and the Economy Watchers survey, and Canada has labour data. Both Australia’s RBA and India’s RBI are seen hiking rates a further 25 bps to 3.35% and 6.50% respectively, and there are plenty of Fed, ECB and BoE speakers, which will be of particular interest after last week’s strong US labour data totally wrong footed markets wishful seeing ‘dovish’ spin on the Fed, BoE and ECB meetings. Monday night brings the US State of the Union address, while Thursday and Friday see a special EU Summit to discuss the European Commission’s Green Deal Industrial Plan that is intended to act as a counter to the US Inflation Reduction Act, though divisions within the EU over the proposals run very deep.
In the commodity space, the EIA publishes its Short Term Energy Outlook, while a busy run of S&D reports will be the focus for agricultural markets, headlined by the USDA’s WASDE, accompanied by China’s CASDE and Brazil’s CONAB Agri and UNICA Sugar data, and StatsCan grains and oilseeds inventories. The EU’s ban on seaborne imports of Russian refined oil products comes into effect, and as has been noticed by some observers, it may be the middlemen and services providers (insurance, logistics) that feel the biggest challenges and squeezes as a consequence.
Corporate earnings highlights for the week as per Bloomberg News: AbbVie, Activision Blizzard, Adyen, AP Moller-Maersk, Apollo Global Management, Astellas Pharma, AstraZeneca, Banco Bradesco, Bharti Airtel, BNP Paribas, BP, British American Tobacco, Brookfield, Brookfield Asset Management, Carrier Global, CDW, Centene, Chipotle Mexican Grill, CME Group, Credit Agricole, Cummins, CVS Health, Daikin Industries, Deutsche Boerse, Dexcom, DNB Bank, Dominion Energy, Duke Energy, DuPont de Nemours, Eaton, Emerson Electric, Enbridge, Enphase Energy, Equifax, Equinor, Fiserv, Fortinet, Fujifilm, Gartner, Hilton Worldwide, Idexx Laboratories, Illumina, Intact Financial, International Flavors & Fragrances, Iqvia, Itau Unibanco, KBC Group, KKR, L’Oreal, Linde, Mettler-Toledo International, Motorola Solutions, Neste, Nintendo, NT&T, O’Reilly Automotive, On Semiconductor, PayPal Holdings, PepsiCo, Philip Morris International, Prudential Financial, S&P Global, Sampo, Semiconductor Manufacturing International, Siemens, Simon Property Group, SoftBank Group, Sun Life Financial, Swisscom, Thomson Reuters, Tokyo Electron, TotalEnergies, Toyota Motor, TransDigm Group, Transurban Group, Uber Technologies, Unilever, Vertex Pharmaceuticals, Vestas Wind Systems, Vinci, Walt Disney, Willis Towers Watson, Yum China, Yum! Brands, Zurich Insurance.
To view the full report and to sign up for daily market commentary please email email@example.com
The information within this publication has been compiled for general purposes only. Although every attempt has been made to ensure the accuracy of the information, ADM Investor Services International Limited (ADMISI) assumes no responsibility for any errors or omissions and will not update it. The views in this publication reflect solely those of the authors and not necessarily those of ADMISI or its affiliated institutions. This publication and information herein should not be considered investment advice nor an offer to sell or an invitation to invest in any products mentioned by ADMISI.
© 2023 ADM Investor Services International Limited.
Risk Warning: Investments in Equities, Contracts for Difference (CFDs) in any instrument, Futures, Options, Derivatives and Foreign Exchange can fluctuate in value. Investors should therefore be aware that they may not realise the initial amount invested and may incur additional liabilities. These investments may be subject to above average financial risk of loss. Investors should consider their financial circumstances, investment experience and if it is appropriate to invest. If necessary, seek independent financial advice.
ADM Investor Services International Limited, registered in England No. 2547805, is authorised and regulated by the Financial Conduct Authority [FRN 148474] and is a member of the London Stock Exchange. Registered office: 3rd Floor, The Minster Building, 21 Mincing Lane, London EC3R 7AG.
A subsidiary of Archer Daniels Midland Company.
© 2021 ADM Investor Services International Limited.
Futures and options trading involve significant risk of loss and may not be suitable for everyone. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. The information and comments contained herein is provided by ADMIS and in no way should be construed to be information provided by ADM. The author of this report did not have a financial interest in any of the contracts discussed in this report at the time the report was prepared. The information provided is designed to assist in your analysis and evaluation of the futures and options markets. However, any decisions you may make to buy, sell or hold a futures or options position on such research are entirely your own and not in any way deemed to be endorsed by or attributed to ADMIS. Copyright ADM Investor Services, Inc.